NEW YORK, Nov. 25 (GenomeWeb News) - 

Tripos said last week that Pfizer will not renew a four-year file-enrichment collaboration that began in 2001.

Tripos received around $90 million over the project, in which it designed, synthesized, and purified a library of drug-like compounds for the pharmaceutical firm. The collaboration will end next month.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.